Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) Sets New 1-Year High – What’s Next?

Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU)’s share price hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $218.00 and last traded at $211.95, with a volume of 206368 shares changing hands. The stock had previously closed at $200.41.

Direxion Daily S&P Biotech Bull 3x Shares Price Performance

The business’s 50 day moving average price is $182.61 and its 200-day moving average price is $170.70.

Institutional Investors Weigh In On Direxion Daily S&P Biotech Bull 3x Shares

A number of institutional investors have recently modified their holdings of the stock. Squarepoint Ops LLC raised its stake in shares of Direxion Daily S&P Biotech Bull 3x Shares by 33.2% in the 2nd quarter. Squarepoint Ops LLC now owns 161,146 shares of the company’s stock valued at $9,171,000 after purchasing an additional 40,157 shares in the last quarter. Tower Research Capital LLC TRC raised its stake in Direxion Daily S&P Biotech Bull 3x Shares by 664.7% during the third quarter. Tower Research Capital LLC TRC now owns 58,171 shares of the company’s stock worth $5,445,000 after acquiring an additional 50,564 shares during the period. JPMorgan Chase & Co. acquired a new stake in Direxion Daily S&P Biotech Bull 3x Shares during the third quarter worth about $3,208,000. Renaissance Technologies LLC raised its stake in Direxion Daily S&P Biotech Bull 3x Shares by 10.6% during the fourth quarter. Renaissance Technologies LLC now owns 22,900 shares of the company’s stock worth $3,650,000 after acquiring an additional 2,200 shares during the period. Finally, Virtu Financial LLC acquired a new stake in Direxion Daily S&P Biotech Bull 3x Shares during the third quarter worth about $1,757,000.

Direxion Daily S&P Biotech Bull 3x Shares Company Profile

The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.